The Monoamine Oxidase A gene promoter repeat and prostate cancer risk

Prostate

Volumn 72, Issue 15, 2012, Pages 1622-1627

  White, Thomas A ^a,b   Kwon, Erika M ^c   Fu, Rong ^a   Lucas, Jared M ^a   Ostrander, Elaine A ^c   Stanford, Janet L ^a,b   Nelson, Peter S ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

MAOA; polymorphism; prostate cancer

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; VARIABLE NUMBER OF TANDEM REPEAT;

ADENOCARCINOMA; ADULT; AGED; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MONOAMINE OXIDASE; NEOPLASM METASTASIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84867072140     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22515     Document Type: Article

References (17)

1. Tonks NK,. Redox redux: Revisiting PTPs and the control of cell signaling. Cell 2005; 121 (5): 667-670.
2. Gunter TD, Vaughan MG, Philibert RA,. Behavioral genetics in antisocial spectrum disorders and psychopathy: A review of the recent literature. Behav Sci Law 2010; 28 (2): 148-173.
3. Yi H, Akato Y, Maruyama W, Chen K, Shih J, Naoi M,. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells. J Neurochem 2006; 96 (2): 541-549.
4. Maragos WF, Tilman PA, Chesnut MD, Jakel RJ,. Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions. Brain Res 1999; 834 (1-2): 168-172.
5. Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC,. Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochem Res 2004; 29 (4): 741-746.
6. True L, Coleman I, Hawley S, Huang CY, Gifford D, Coleman R, Beer TM, Gelmann E, Datta M, Mostaghel E, Knudsen B, Lange P, Vessella R, Lin D, Hood L, Nelson PS,. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc Natl Acad Sci 2006; 103 (29): 10991-10996.
7. Zhao H, Nolley R, Chen Z, Reese SW, Peehl DM,. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells. Differentiation 2008; 76 (7): 820-830.
8. Sabol SZ, Hu S, Hamer D,. A functional polymorphism in the Monoamine oxidase A gene promoter. Hum Genet 1998; 103 (3): 273-279.
9. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK,. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomark Prev 1999; 8 (10): 881-886.
10. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL,. Statin use and risk of prostate cancer: Results from a population-based epidemiologic study. Am J Epidemiol 2008; 168 (3): 250-260.
11. Waksberg J,. Sampling methods for random-digit dialing. J Am Stat Assoc 1978; 73: 40-46.
12. Sambrook J, Fritsch EF, Maniatis T,. Molecular Cloning: A Laboratory Manual, Vol. 1-3. New York: Cold Spring Harbor Laboratory Press; 1989. pp. 1-3.
13. Breslow NE, Day NE,. Statistical methods in cancer research, volume 1-The analysis of case-control studies. Lyon: Int Agency Res Cancer; 1980; 1: 202-205.
14. Dubin N, Pasternack BS,. Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol 1988; 123: 1101-1117.
15. Dizeyi N, Hedlund P, Bjartell A, Tinzl M, Austild-Taskén K, Abrahamsson PA,. Serotonin activiates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines. Urol Oncol 2011; 29 (4): 436-445.
16. Philibert R, Wernett P, Plume J, Packer H, Brody G, Beach SR,. Gene environment interactions with a novel variable monoamine oxidase A transcriptional enhancer are associated with antisocial personality disorder. Biol Psychol 2011; 87: 366-371.
17. Philibert R, Gunter T, Beach S, Brody G, Madan A,. MAOA methylation is associated with nicotine and alcohol dependence in women. Am J Med Genet B Neuropsychiatr Genet 2008; 147B (5): 565-570.